Oruka Therapeutics, Inc. ORKA Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s payments to acquire property, plant, and equipment?
- Oruka Therapeutics, Inc. (ORKA) reported payments to acquire property, plant, and equipment of $73K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s payments to acquire property, plant, and equipment changed year-over-year?
- Oruka Therapeutics, Inc.'s payments to acquire property, plant, and equipment increased by 461.5% year-over-year, from $13K to $73K.
- What is the long-term trend for Oruka Therapeutics, Inc.'s payments to acquire property, plant, and equipment?
- Over 2 years (2021 to 2025), Oruka Therapeutics, Inc.'s payments to acquire property, plant, and equipment has grown at a 120.5% compound annual growth rate (CAGR), from $43K to $209K.
- What does payments to acquire property, plant, and equipment mean?
- Represents cash outflows used to purchase tangible long-term assets necessary for business operations. This metric serves as a primary indicator of capital expenditure intensity and investment in future production or research capacity.